RETINOID CHEMOPREVENTION TIMING AND DOSE INTENSITY

被引：3

作者：

BAND, PR ^{[1
]}

DESCHAMPS, M ^{[1
]}

ISRAEL, L ^{[1
]}

机构：

[1] CHU AVICENNE,CANCEROL CLIN,BOBIGNY,FRANCE

来源：

关键词：

D O I：

10.3109/07357908909038286

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：205 / 210

页数：6

共 63 条

[1] ALFTHAN O, 1983, EUR UROL, V9, P6
[2] BAND PR, 1982, CANCER TREAT REP, V66, P1759
[3] BAND PR, 1984, PREV MED, V13, P549, DOI 10.1016/0091-7435(84)90023-9
[4] Berenblum I., 1982, CANC COMPREHENSIVE T, VI, P451
[5] BHATTY KA, 1984, BIOGENIC AMINES, V1, P1
[6] BOLLAG W, 1983, CANCER SURV, V2, P293
[7] THERAPEUTIC EFFECTS OF AN AROMATIC RETINOIC ACID ANALOG ON CHEMICALLY-INDUCED SKIN PAPILLOMAS AND CARCINOMAS OF MICE
BOLLAG, W
[J]. EUROPEAN JOURNAL OF CANCER, 1974, 10 (11) : 731 - 737
[8] PROPHYLAXIS OF CHEMICALLY INDUCED BENIGN AND MALIGNANT EPITHELIAL TUMORS BY VITAMIN-A ACID (RETINOIC ACID)
BOLLAG, W
[J]. EUROPEAN JOURNAL OF CANCER, 1972, 8 (06) : 689 - &
[9] INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID
BREITMAN, TR
SELONICK, SE
COLLINS, SJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05): : 2936 - 2940
[10] COHEN SM, 1976, CANCER RES, V36, P2334